Octreotide in the treatment of pthrp related hypercalcaemia in neuroendocrine tumours: a case report and literature review
RA Jones, J O'Grady, S Chambers, N Heaton, JK Ramage & SJB Aylwin
Intro: A subset of pancreatic and gastric neuroendocrine tumours (NET) are associated with hypercalcaemia attributed to tumour secretion of parathyroid hormone related peptide (PTHrP). Hypercalcaemia may be severe and refractory to conventional treatment.